跳至主要内容
临床试验/NCT04969822
NCT04969822已完成不适用

Will Embryo Selection Through Use of Artificial Intelligence (iDA) Perform Equally Compared to Day 5 Morphology?

Vitrolife28 个研究点 分布在 4 个国家目标入组 1,066 人开始时间: 2020年2月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Vitrolife
入组人数
1,066
试验地点
28
主要终点
Clinical Pregnancy Rate

研究概览

简要总结

A non-inferiority, prospective parallel group, multi-center, randomized controlled trial to investigate whether selection of a single blastocyst for transfer using the deep learning tool, iDA, results in non-inferior clinical pregnancy rate compared to trained embryologists using standard morphology criteria.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Women undergoing IVF or ICSI with controlled ovarian stimulation with gonadotrophins and the intention to treat by either transfer of a single fresh embryo on day 5 or in case of a freeze all cycle, the first rewarmed embryo.
  • Age: Up to and including the 42nd completed birthday on the day of randomization.
  • Has at least two early blastocysts on day 5.

排除标准

  • Treatment involving donated eggs
  • Intention to perform any form of preimplantation genetic testing
  • The use of IMSI or polarized light in the ICSI process
  • The use of assisted hatching prior to randomization
  • Previous participation in this RCT
  • Where the cycle is carried out for fertility preservation
  • If a day 2-4 transfer is planned
  • Has a reduced likelihood of obtaining two early blastocysts on day 5 as evidenced by either: an AMH level of <3pmol/L or AFC <5 (if available)

结局指标

主要结局

Clinical Pregnancy Rate

时间窗: After 7-9 weeks of gestation

Ultrasound evidence of an intrauterine pregnancy with a fetal heart observed

次要结局

  • Live Birth Rate(9 months)
  • Positive hCG Rate Per Randomized Patient(Tested on day 9-13 following embryo transfer)
  • Rate of Non-viable Pregnancies(After 7-9 weeks of gestation)
  • Ongoing Pregnancy Rate(After 7-9 weeks of gestation)

研究者

发起方
Vitrolife
申办方类型
Industry
责任方
Sponsor

研究点 (28)

Loading locations...

相似试验